“The integration of OMNIMED SmartOR into Axis’s distinguished bioskills lab facilities across the U.S. dramatically changes the playing field for medical device testing,” said Hugh Dodson, CFO and COO of OMNIMED. “For the first time ever, medical device companies, surgeons and researchers can access real-time data from intraoperative procedures to make educated, informed decisions that will improve performance and guide best practices.”